Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to discuss the Company’s record-breaking revenue for the June 24 quarter and for FY24.
He spoke of the growing adoption of Orthocell’s medical devices, Striate+™ and Remplir™, and the Company’s expansion plans to capture a significant share of the global dental bone regeneration and peripheral nerve repair markets.
<iframe title=”YouTube video player” src=”https://www.youtube.com/embed/Cwb-FshpcKs?si=xTJ-dixRSt6Diioj” width=”560″ height=”315″ frameborder=”0″ allowfullscreen=”allowfullscreen”></iframe>